1971年,上海静安中药切制厂,从本市万年红草药店采用民间验方新鲜垂盆草治疗肝炎,取得较好疗效一事中受到启发,开始研制垂盆草冲剂,并于1972年起正式生产供应。1985年5月上旬,由名老中医董建华教授主持,在北京召开了垂盆草冲剂临床应用经验推广座谈会。会上吕炳奎、方药中、王绵之、颜振华、方祖谦、赵绍琴、谢海洲、冷方南、田德荫等京津地区的中医专家,根据垂盆草冲剂临床观察的详细数据,对它的功效、主治及制作工艺,进行了深入的探讨。认为这种冲剂性能稳定,疗效显著,服用方便,无副作用,可以广泛应用于肝病的临床。为此现将有关情况述之如下。一、品种鉴定决定生产之前,先往浙江、江苏、安徽等地采集标本,专程送请植物分类专家鉴定,然后再确定收购加工生产的基地。当时先后采集到垂盆草原植物有宽叶、狭叶、小叶和佛甲草(Sedum Tineare Thunb)四种,无论从表型,还是从生态偏爱和物候学特征来看,宽叶、狭叶、小 In 1971, Shanghai Jing’an Traditional Chinese Medicine Cutting Factory, from the city’s 10,000-year red herbal shop, used a non-governmental prescription of fresh sarmentosum to treat hepatitis and achieved better curative effects. He was inspired to start the research and development of celandine granules and began formalizing in 1972. Production supply. In early May of 1985, Professor Tung Chee-hwa, a distinguished Chinese medicine doctor, presided over the seminar on the promotion of the clinical application experience of celandine granules in Beijing. Lu Yibing, Fang Fangzhong, Wang Mianzhi, Yan Zhenhua, Fang Zuqian, Zhao Shaoqin, Xie Haizhou, Leng Fangnan, Tian Deyin and other experts from the TCM in Beijing and Tianjin, according to the detailed data of the clinical observation of the Shibapencao granule, its efficacy, indications and production process , conducted in-depth discussion. It is believed that such granules have stable performance, remarkable curative effect, convenient administration and no side effects, and can be widely used in the clinical treatment of liver diseases. To this end, the relevant circumstances are described below. I. Identification of species Before deciding on production, first collect samples from Zhejiang, Jiangsu, Anhui, etc., and send them to a plant classification expert for identification, and then determine the base for acquisition and processing. At that time, there were four species of broad-leaved, narrow-leaved, leaflet, and Sedum Tineare (Thunb) collected from the savannah grassland, regardless of phenotype or ecological preference and phenological characteristics. small